Try our Advanced Search for more refined results
Health - February, 2012
290 articles
- HHS Finds $1B in Home Health Medicare Claims Miss Data
- 3rd Circ. Says AIG Unit Doesn't Owe Hospital Group Coverage
- Consumer Groups Say Aneurysm Fixer Needs More FDA Tests
- Abbot Targets Amneal In Latest Suit Over Generic Niaspan
- Bill Would Create Registry Of Legit Web Pharmacies
- Indie Pharmacies Claim CMS Rule Stifles Competition
- Current Trends In Health Care Fraud Enforcement
- House Panel Votes To Kill Health Law's Medicare Costs Board
- Ex-Exec Can't Support FCA Claims, Pfizer Tells 1st Circ.
- Dainippon To Pay Up To $2.6B For Cancer Drug Developer
- GOP Lawmakers Lash Out At Employer Contraception Rule
- Bayer, Others Exit Price-Fixing Suit After High Court Win
- Fresenius Must Sell Clinics To Finish $2B Liberty Buy: FTC
- Businesses Urge Delay Of Health Benefit Explanations
- Families Toss Bid To Renew J&J, Omnicare Antitrust Suit
- Statins Carry Small Risk Of Diabetes, FDA Warns
- Merck Failed To Probe Diabetes Drugs For Risks: FDA
- Eisai Can't Pry Transcripts From 2003 Aventis Antitrust Suit
- Insurer Seeks To Toss Perkins Coie Atty's Testimony
- Sebelius, Lawmakers Spar Over Long-Term Medicare Solvency
- Invalidity Claim To Be Tried In Pitt, Varian Patent Fight
- Feds Charge Doctor In $375M Medicare Fraud
- Abbott Lodges New Zemplar Patent Suit Against Hospira
- Lawmakers Mull Wasteful Spending Revealed In GAO Report
- Diagnostics Co. Alere To Acquire EScreen For $270M
- Marine Polymer — Take 2
- Doctors Urge Hill To Get Rid Of Payment Advisory Board
- FDA Warnings Don't Always Start Limitations Clock: NJ Court
- Mandarin Capital Triples Investment In Italian Pharma Co.
- Buying Groups Shook Down Vaccine Customers, Sanofi Says
- Mylan Ends Calif. Drug Price Inflation Claims For $57M
- FDA Rejects Preterm Birth Drug From Watson, Columbia
- Glenmark Recalls Birth Control Over Faulty Packaging
- FTC To Challenge Ga. Hospital Merger In High Court
- Bradley Arant Snags Health Atty From Balch & Bingham
- HHS Proposes Specs For Health Plan 'Metal Tiers'
- Shareholders Win Cert. In Suit Over Matrixx Cold Medicine
- High Court Again Denies Bid To Argue For Kagan Recusal
- The Changing Face Of US Health Care
- Where Is The Corporate Integrity Agreement?
- Hypertension Drug's Labeling Problems Prompt GSK Recall
- Blue Cross Must Face Autism Therapy Action: 6th Circ.
- Disease Groups Beg Congress For Antibiotics R&D Boost
- WellCare's $137M Medicaid Fraud Payout Clears Last Hurdle
- Part C Insurers Could Face Mandatory Fraud Reporting
- Nixon Peabody Lands Ex-Pillsbury Gov't Contracts Pro
- Warner Chilcott Subpoenaed Over Marketing, Off-Label Use
- Debtholders Can't Get $40M From US Oncology For Now
- Crowell Adds Dorsey Commercial Litigation Pro In Calif.
- Varian Hit With $37M Verdict In Pitt Patent Suit
- Regulatory Demands To Spur Health M&A in 2012: Report
- CMS Proposes Stage 2 Goals For Health E-Records
- 7 States Try To Take Down Obama Contraception Rule
- House Bill Aims To Rein In State Drug, Device Inspections
- GSK, Teva Face Antitrust Class Action Over Lamictal Deal
- 6th Circ. Scuttles Blue Cross Appeal In Antitrust Suit
- Ex-Unilab Atty Can Pursue FCA Claims, 2nd Circ. Hears
- Texas Drug Fraud Law Preempted In J&J Suit: 5th Circ.
- Carlyle Eyes Sale Of $497M Stake In Brazil's Qualicorp
- Hospital Administrator Cops To $116M Medicare Scam
- Faulty Vials Prompt Blood Pressure Med Recall
- The Pitfalls Of Paperless Discovery
- Wash.'s Contraceptive Sales Rules Unconstitutional: Judge
- New Rules Let States Opt Out Of Health Care Reform Law
- 11th Circ. Revives $69M Fraud Suit Against Medco
- Pfizer Unit Scores More Time In Ch. 11 For Asbestos Dealings
- Genetic Disorder Patients Take Aim At US Over Drug Shortages
- J&J Tries To Ease EU Concerns Over $21B Synthes Deal
- Justices Remand Challenge To Calif.'s Medicaid Cuts
- Insurer Aims To Duck Coverage Of Omeros FCA Suit
- Fla. Catholic University Sues Over Contraception Rule
- 2nd Circ. Bars Trusts From $138M Biovail, Investors Deal
- 8 States Probe Abbott's Marketing Of Anti-Seizure Drug
- SNR Denton Defamation Claims Revived In Secrets Row
- US Issues $639M In Loans For Insurance CO-OPs
- $1.7B Humira IP Verdict Won't Get Supreme Court Review
- Dental Center Co. Seeks Sale To Root Out Fraud Claims
- CMS Sunshine Rule Will Unfairly Burden Docs: AMA, Others
- Forest's COPD Drug May Have Added Heart Risks: FDA
- 13 States Back Medicaid Expansion In High Court Brief
- Allergan, Others Sought Pinkeye Treatment Monopoly: Suit
- Rotech Sues VA Over Home Oxygen Contract
- Cellectis Hit With New Genome Engineering IP Suits
- Mylan Settles Defamation Suits Against Pittsburgh Paper
- FDA Calls For Voluntary Reporting Amid Drug Shortages
- Teva To Pay $270M In Propofol Hepatitis Suits
- Genomma Bids $834M For Prestige Brands
- Schering-Plough Strikes $12.5M Deal In ERISA Suit
- High Court Nixes Nursing Home Death Arbitration Ruling
- Aetna Fires Back At Blue Cross Over Mich. Antitrust Suit
- Stop The Madness (Before It Starts): UCL Abstention
- Omnicare Abandons $441M Offer To Buy PharMerica
- Huron, Empire Can't Duck $50M St. Vincent FCA Suit
- NC Gets Health Insurance Waiver While Wis. Misses Bar
- Novartis Must Note Blood Pressure Drug Risks On EU Labels
- J&J Unit Recalls Infants' Tylenol Over Dosing Device
- Amgen Employees Press 9th Circ. To Revive ERISA Action
- Pryor Cashman Nabs IP Partner From Milbank Tweed
- PhRMA, Others Urge CMS To Back Off On Sunshine Rule
- 11th Circ. Seeks Fla. High Court's Input On Insurance Tussle
- Bird & Bird Tightens Africa Ties With Tunisian Alliance
- Bristol-Myers Subpoenaed By DOJ For Abilify Info
- Congress Passes Payroll Tax Cut, 'Doc Fix' Deal
- Increasing Access To Innovative Biomedical Technology
- In Promotional Labeling, Size Matters
- Law School, Meet Litigation PR ...
- New Bill Would Give FDA Greater Development, Review Tools
- 'Doc Fix' Deal Slashes Bad Debt Payments, Prevention Fund
- Alleged Gangster Sentenced In $100M Medicare Fraud Case
- Ex-National Century Exec's Sentence Stands: 6th Circ.
- Jury Convicts 4 In $29M Medicaid Billing Scheme
- CVS Escapes Class Action Over Health Data Sales
- Catholic Group Sues White House Over Contraception Rule
- Shionogi Scuttled Deal By Destroying Fenoglide Pills: Suit
- USPTO Gene Test Fight Pits Patients Against Patents
- WTC Panel To Back Cancer Coverage For 9/11 Victims: CDC
- Sens. Demand Info From Ben Venue Over Drug Shortage
- Genzyme Recalls Leukemia Meds Over Factory Concerns
- Avoiding Union Ire With Consistent Policy Enforcement
- Ex-Olympus Chief, 6 Others Arrested Over Accounting Scheme
- Calif. High Court Takes Up Cipro Pay-For-Delay Suit
- GAO Favors Protesters In Row Over $92M Medicare Contract
- HHS Delays ICD-10 Coding Switch Due To Provider Complaints
- Jury Awards Promega $52M In Genetic Test Kit IP Suit
- 7th Circ. Paves Way For More Antitrust Actions Over Tie-Ups
- Probe Into FDA Monitoring Of Whistleblower Emails Expands
- 3rd Circ. Trims Injunction In Stryker Employee Poaching Suit
- Ky. Court Shuts Down Class Cert. In Vioxx Fraud Action
- M&A Pro Jumps To Arnold & Porter From Allen & Overy
- GOP Signals Fight Ahead Over Medical Device User Fees
- Canopy Co-Founder Gets 13 Years For $93M Investment Scam
- NY To Examine Insurers' Data Used To Request Rate Hikes
- NuVasive Can't Boot Patent After $101M Infringement Verdict
- Illumina Investors Claim Goldman Bias In Suit Over Roche Bid
- Graceway Settles Claims With GTCR For $6M
- HHS, DOJ Recoup Record $4.1B From Health Fraud In FY 2011
- Judge Stays Pa. Hospital Antitrust Suit Amid Bias Claims
- Lawmakers Press FDA To Get Tough On Drug Trial Reporting
- Counterfeit Avastin Found In US, Roche Says
- Cell Therapeutics Settles Investor Lawsuit For $19M
- EDG Partners Closes 2nd Health Care Fund At $178M
- Genzyme, Insurer Settle Coverage Suit Over $64M Deal
- CMS Floats 60-Day Medicare Overpayment Refund Rule
- McKesson Can't Duck FCA Suit Over Alleged Kickbacks
- Bradley Arant Snags 4 Attys For Ala.
- AlloDerm Insurer Sues Over Coverage For Alleged Injuries
- 31 Groups Call On US To Settle Guatemala STD Case
- 'Independent Practice,' Collective Enforcement
- Waste Not, Risk Not
- Omnicare Dodges Investor Action Over Kickback Claims
- Biogen To Spend $75M For Fibrosis Drug Co. Stromedix
- Insurer Wants Out Of J&J Supplier's Bug Infestation Suit
- Facebook, Others Weigh In On Fed. Circ. Intervening Rights Case
- Obama Budget Would Trim Health Entitlements By $350B
- Obama's 2013 Budget Targets Pay-For-Delay Deals
- Dental Device Maker Halts Operations Amid FDA Warnings
- Judge OKs 3 New Bellwethers In NuvaRing MDL
- Former DOJ Atty To Lead Bass Berry's DC Office
- Drug Industry Balks At Obama's Budget Proposals
- Medtronic Pushes For Royalties In NuVasive Patent Row
- RI Hospital Puts Up $5M To End False Claims Allegations
- US, 4 States Join CVS Caremark Insurance Fraud Action
- Weil Gotshal Grabs Dechert Litigation Duo For NY Office
- Express Scripts, Medco Send FTC More Info On $29B Merger
- Kirkland & Ellis Helps Linden Buy SeraCare For $82M
- Mylan Must Shell Out $18M To Sunovion In Xopenex Patent Suit
- Delays Cost Cephalon TRO In Anti-Epilepsy Patent Suit
- Biosimilar Guidance Silent On Industry's Biggest Questions
- Fed Circ. Upholds $371M Award In Bard Graft Patent Suit
- Nautilus Falsely Marked Exercise Equipment: Judge
- Merck, Bayer Target Watson Over Generic Beyaz Birth Control
- Mylan Escapes 6 Cases In Darvocet, Darvon MDL
- US Sues Dallas Drug Compounder Over 3 Colchicine Deaths
- Pfizer Bests Investor Suit Over Alzheimer's Drug Trial
- 5th Circ. Won't Rehear Texas Abortion Law En Banc
- Scrushy Appeals Bribery Conviction To Supreme Court
- Patient Wants High Court To Take Up Genzyme Negligence Suit
- Judge Says MediSys Wage Suit Should Be Tossed
- Jackson Lewis Gets New Partners In Boston, NYC
- Sens. Press OMB For Delayed Medical Device Rule
- Judge Misread Patent Claims, Sanofi Tells Fed. Circ.
- Obama Announces Compromise On Birth Control Rule
- Whistleblower Settles Blackstone FCA Kickback Claims
- A Green Light For Repetitive Class Action Litigation
- Revised Removal Statutes — Possibilities, Pitfalls: Part 2
- Jury Clears Sigma In $172M Medical Pump Patent Suit
- Espada Accuses Gov't Of Misconduct In Record Seizure
- Health Insurers Slam HHS Rule To Simplify Policy Explanations
- Case Study: Messner V. Northshore
- FDA Releases Guidance On Biosimilar Approvals At Last
- Ex-Leo Pharma Sales Reps Launch OT Class Action
- Feds Seek 15 Years For Ex-Canopy Exec's $93M Fraud Role
- Ex-Allergan President Escapes Investor Suit Over Exec Pay
- AstraZeneca Can't Block Generic Crestor: Fed. Circ.
- Covington Scores Wilson Sonsini Corporate Team
- 9th Circ. Axes Lawsuit Over Stores' Drug Pricing Role
- Drug Cos. To Fund FDA Generics Reviews Under New Bill
- Catholic TV Network Sues US Over Birth Control Mandate
- Business Associates Beware: Accretive's HIPAA Suit
- Ex-Takeda Exec Settles SEC Insider Trading Claims
- Ex-Citigroup Exec Hits Abbott With Humira Cancer Suit
- Doughty Hanson Picks Up Spanish Hospital Group For $472M
- No Quick Win For Ex-KV Pharma CEO On Criminal Costs
- How They Won It: Ropes & Gray Rescues Stryker Biotech
- FDA Panel Votes Against Amgen's Xgeva For Prostate Cancer
- Drug Co. Dava Pays $11M To End Medicaid Rebate Suit
- Ernst & Young Censured, Fined $2M Over Faulty Audits
- Continental Ducks Coverage For $198M Anthem Settlement
- Mylan Can't Launch Doryx Generic Just Yet
- Popular Acid Reflux Drugs Can Trigger Infections: FDA
- Insurer Dodges Malpractice Liability Over Unfiled Suit
- PE's Healing Touch Faces Test In Hospital Buys
- FDA Faces Renewed Battle Over Plan B Age Restrictions
- Watson, J&J Settle Over Birth Control Generic
- Qui Tam Trends In 2011, Predictions For 2012
- Benefit Corps. — A New Structure For The New Economy
- Illumina Board Urges Investors To Reject $6B Roche Bid
- Feds Worried Over Espada Atty's Conflicts Of Interest
- Fed. Circ. Finds Exception To Late Interference Claims
- Bayer, Merial Flea Product Class Actions Merged In Ohio
- Hospitals Will Pay DOJ $12M To End Medicare Fraud Claims
- DC Circ. Says Seniors Can't Disown Medicare Eligibility
- IP Attys Blast USPTO's Supplemental Exam Rules
- Bingham Aids Platinum Equity's Medical Equipment Co. Buy
- MDL Panel Sends Surgical Mesh Battles To W.Va.
- MGH Didn't Credit Researchers For Patents, Fed. Circ. Hears
- BioMed Realty Brings In Mass. Office Space For $119M
- Judge Upholds FDA Approval Of Generic Lovenox
- MoFo Adds Howard Hughes GC To Life Sciences Team
- DOL Tells High Court Drug Sales Reps Deserve OT Pay
- A Real Headache Of A Disability Claim
- Pfizer Faces Antitrust Suit Over Generic Lipitor Delay
- Judge Can't Stop Contentious Texas Abortion Law
- Health Mandate Violates Constitution, Critics Tell High Court
- Fed. Circ. Lifts Lupin Ban In Generic Fortamet Fight
- Wake Forest Blasts Jury Interrogatories In Fed. Circ. IP Case
- ProMedica Begs FTC Not To Make It Divest Ohio Hospital
- 5th Circ. Leaves Insurers On Hook In Ambulance Injury Suit
- Ranbaxy Exits Pfizer's Suit Over Generic Rapamune
- Greenberg Adds Reed Smith Atty To Health Products Group
- RiverVest Investor Payouts Off $1B Sales Top Charts
- Mylan, Shire Battle Again Over Generic Vyvanse
- IRS Lays Out Plan For New Medical Device Tax
- Who's A Federal Contractor? You Just Might Be
- Smith & Nephew Pays $22M To Settle US Bribery Allegations
- BioSante Female Libido Drug Hype Was Fraudulent: Suit
- Vitamin Buyers Get Class Cert. In Bayer Prostate Health Case
- DOJ, McDermott Call Quits On Hospital Merger FOIA Suit
- Attys' Fees Sink Proposed Adventist FLSA Settlement
- Cancer Drug Firm Duped Investors In $26M Offering: Suit
- Sen. Looks To Close Cost Gap In Hospitals' Implant Buys
- Columbia Labs Sued Over Drug-Related Stock Drop
- Quest Asks 2nd Circ. To Bar Ex-Atty From Kickback Suit
- GAO Scraps Protests Over $73M Medicare Auditing Contract
- Wheelchair Fraud Prevention Programs To Launch In June
- Trends In M&A, Spin-Offs, Hostile Deals And PE
- FTC Won't Get Monitor For ProMedica Hospital Operations
- Impax, Teva Put Generic-Wellbutrin MDL To Bed
- Senate Bill Would Streamline FDA's New Device Reviews
- 7th Circ. Shuts Down Abbott Workers' Benefit Appeal
- NLRB Wrongly Awarded Nurses Back Pay, DC Circ. Hears
- Highlighting 'Pay For Delay' Concerns
- A Little 'Guidance': All You Need For Preemption?
- Revised Removal Statutes — Possibilities, Pitfalls: Part 1
- Health Info Services Co. Jobson Heads To Ch. 11
- EU Seeks Deeper Study Of Faulty Breast Implants
- DLA Piper Snags McDermott Health Care Team
- 7 Convicted In NY Presbyterian Hospital Kickback Plot
- Grassley Grills FDA Over Whistleblower Treatment
- Dentsply Blames Lewis & Roca For Contract Case Loss
- Sen. Blasts Express Scripts, Medco Deal On Antitrust Fears
- Angioblast Loses Contract Counterclaims Against UBS
- CMS Won't Change Emergency Care Rules For Inpatients
- Ex-Reed Smith Life Sciences Pro Jumps To Hogan Lovells
- Bill Targets 'Loophole' In FDA Device Approval Process
- TheraMax Cold And Flu Can't Treat Either Ailment: Suit
- Witness Must Testify In Medtronic Off-Label Suit: Judge
- Plastic Surgeons In Italy Sue Over Faulty Breast Implants
- Kappos Says Prior Use Rule Shouldn't Be Changed For Now
- Astellas Can't Shake MDL Over Generic Prograf Delays
- House To Subpoena VA Docs Over Off-Contract Drug Buys
- 5th Circ. Allows State Claims In Stryker Implant Suit
- FDA Aims To Boost Inspections Of Foreign Drugmakers
- Davis Polk Nabs Former Deputy AG
- Pfizer Recalls Birth Control Pills After Packaging Mix-Up
- Mitigating Risk In Mass Nano Torts
- The Importance Of Legal Audits
- The Global Reach Of Stem Cell Research Patents
- Territory Managers Hit Quest With Wage Class Action
- Crowell Adds 3 Kilpatrick Townsend Drug IP Specialists